The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity - Wikidata - wikimedia - TriplyDB

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

http://www.wikidata.org/entity/Q24806953

about

A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma Granzyme B; the chalk-mark of a cytotoxic lymphocyte Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantation Pushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology Rad52 deficiency decreases development of lung squamous cell carcinomas by enhancing immuno-surveillance.DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor.Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells.Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.Autologous tumor rejection in humans: trimming the myths.A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors.Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms.Vaccination with agonist peptide PSA: 154-163 (155L) derived from prostate specific antigen induced CD8 T-cell response to the native peptide PSA: 154-163 but failed to induce the reactivity against tumor targets expressing PSA: a phase 2 study in p ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials.ELISpot for measuring human immune responses to vaccines.Immunological monitoring of the tumor immunoenvironment for clinical trials.Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer.Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells.Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot.Characterization of T-cell responses against IκBα in cancer patients.Guidelines for the automated evaluation of Elispot assays.Functional characterization of Foxp3-specific spontaneous immune responses.Workplace Health Promotion and Wellbeing.Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β+ T Cells and Differentiated γδ T Cells Alongside a Regulatory Response Mediated by FOXP3+ T Cells and Immunoregulatory Molecules.

P2860

Q24681501-629AF6A6-1639-4935-8A14-D24B42E8AB34 Q24794483-52A93C97-409C-44DB-B8C0-5D7010431717 Q24800129-9F9AA869-D199-4FD4-B6B4-3E4D3476C8A4 Q26861648-2A3FB8BF-278B-4E70-9D74-C90C11322602 Q30416916-F39EF0E1-055B-4D4B-8F46-C9ECB9E0297F Q30438965-481A4D7B-FFD3-468B-8A42-DA219BABBF7C Q33798257-984DB58C-745C-4D4B-BA93-C489FF68B2A3 Q34305417-1100E7C8-8CDF-418F-84BC-E84A84EC2ED3 Q35063668-46C1874F-5BE5-4C50-A4B5-32B18104450C Q35140402-814812B9-E1A8-4EB2-A361-7DC4CFAEFC94 Q35269599-87E384F9-D133-4CFA-96DD-698A0EDE2F96 Q35864700-94BBEA26-28A3-495D-B173-C74238052AD9 Q35896241-73BCBBA7-9998-4E8D-BD31-3FB9DDCCA508 Q36015439-5057803C-F118-45F2-87FB-CE1278D17A40 Q36057500-B81A9040-7439-448D-B340-E4795F77ABF0 Q36569014-FA7F77F6-D489-4858-8F0A-1B4560529130 Q36607578-39E3752D-B274-4EE7-9529-0A88235483A8 Q37337824-7E875EFB-8887-4049-9AB5-B8F844A1B3E8 Q37379219-E528578B-4D8B-4090-8208-1AB69348321B Q37512173-BA36AF15-45B6-4D95-92EC-AF684B34F85D Q37857243-09A5EFC8-A468-47AE-A34A-D885F8E8B9FB Q37955680-3AE55445-3FCC-4EA4-A784-95ACF8A8D215 Q38590722-4AABA7CB-30C4-498B-9474-6A0B530216D2 Q38785195-C0665B64-B84F-43D8-8D43-1A4B70440868 Q39575598-6B898BF5-F5C9-4C05-8021-97064A1C52D8 Q40179067-92CC555D-CAE4-413A-97B9-FBA639FA92B4 Q40339502-1CBC1305-258A-4E29-AAD3-669F9B5B0465 Q40439479-EFAC590E-4372-4B5F-9D09-B13C033A9DC0 Q41889515-5A7548CC-73DA-4CBC-82DE-993538EA12E4 Q42403177-287E2807-65B5-4EAB-8BD1-632AB73682CE Q49020806-7FF40113-26B2-49A2-841C-6C541F7C595D Q50868528-192AC71D-6207-4251-8659-F9305A298698 Q54854522-AF79DFCE-6D32-4222-BD6A-70BF959C8893 Q55292386-9A3C4C51-E1CF-44D2-A37D-7BB47853074B

P2860

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

http://www.wikidata.org/entity/Q24806953

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@ast

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@en

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@nl

type

label

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@ast

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@en

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@nl

prefLabel

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@ast

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@en

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@nl

P1433

Q24806953-4C0CE729-C6D5-4E85-8E56-61578A461218

P1476

Q24806953-F05E5608-FD7D-45C7-A474-38FAF4795244

P2093

Q24806953-093ED6E1-F2CF-4FC5-AC2E-04F9848AD1EB

Q24806953-38107CDD-DE4D-4FF0-8483-C36F93429828

Q24806953-51F4F35C-EF83-4C8F-8430-40A508A64386

Q24806953-62102FC3-DF8B-481D-96E9-B1CE3BFD86DD

Q24806953-6718A793-D545-41DE-AD57-4BD3BE77D1AE

Q24806953-A7A37787-B84D-47E7-B14D-51E27EF922D1

Q24806953-F1031D19-D16E-4C4A-8516-EBA63A6BFC03

P2860

Q24806953-0F132AD5-99AC-44F3-9EB5-11D9C5FE97E0

Q24806953-0F353A4D-22B4-48C4-BD8E-E9575EBBA45B

Q24806953-168B7114-E2CB-457E-9168-75DE8ADB1843

Q24806953-2177C12C-BAFF-4219-A504-775BC7AD70D2

Q24806953-23A52FE6-17A6-4EC1-9990-81BF3F71B1D4

Q24806953-2746E292-ADAB-4EE5-8288-65D981A5B519

Q24806953-38385FB6-F2F5-4098-99FC-B74997DE635A

Q24806953-3A823540-A7FC-4A21-8CDD-BAE47075388D

Q24806953-3C834874-4D1F-48E9-B119-5AEF8A9A8BB1

Q24806953-43131353-8F3A-4190-A656-1597F926D706

P2888

Q24806953-C6F01F61-6FD7-40AC-A255-613AC9F43926

P304

Q24806953-EC7A61D9-688A-4FED-A497-CCF24633FCE6

P31

Q24806953-13E40E0D-6FD4-438B-8B3F-3581D237E0A2

P3181

Q24806953-D0DB1C37-DC02-49BE-876A-E856D2AE3B2D

P356

Q24806953-A98036EE-4445-403A-A7D7-EEB657B69AFB

P433

Q24806953-F4E7D248-A485-4C2B-A769-9318A48728A3

P478

Q24806953-F9212DBD-E722-4338-8CB4-F4AEC90AE12F

P577

Q24806953-7CE999DC-1C62-44E6-A4B9-5966A3F1F32F

P5875

Q24806953-2BFB2F59-E7DC-422E-871E-3A3E99266513

P6179

Q24806953-44331611-CF79-46B2-86F6-BD9D67AC1BFA

P698

Q24806953-CD090B13-2467-4539-BA81-02E18C871C6B

P921

Q24806953-6D298F14-1E29-489E-B474-5B38E794A605

P932

Q24806953-679EFE1D-7321-460F-9008-725E73CED26D

P3181

P356

P1433

Journal of Translational Medicine

P1476

The Granzyme B ELISPOT assay: ...... ing cell-mediated cytotoxicity

@en

P2093

Anatoli Malyguine

http://www.w3.org/2001/XMLSchema#string

Eric Derby

http://www.w3.org/2001/XMLSchema#string

Kimberly Shafer-Weaver

http://www.w3.org/2001/XMLSchema#string

Michael Baseler

http://www.w3.org/2001/XMLSchema#string

Susan Strobl

http://www.w3.org/2001/XMLSchema#string

Thomas Sayers

http://www.w3.org/2001/XMLSchema#string

Tracy Ulderich

http://www.w3.org/2001/XMLSchema#string

P2860

Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects

Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.

Accessing complexity: the dynamics of virus-specific T cell responses.

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.

Unlocking the secrets of cytotoxic granule proteins.

Preferential localization of effector memory cells in nonlymphoid tissue.

Lymphocyte-mediated cytotoxicity.

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments.

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma.

P2888

P304

14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1694777

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1479-5876-1-14

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8941001

http://www.w3.org/2001/XMLSchema#string

P6179

1048389214

http://www.w3.org/2001/XMLSchema#string

P698

14697097

http://www.w3.org/2001/XMLSchema#string

P921

P932

317386

http://www.w3.org/2001/XMLSchema#string